Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation (AF).

Flossing regularly may lower the risk of some strokes as well as a type of irregular heart rhythm that can increase stroke ...

Regular tooth flossing is tied to a lower risk for ischemic stroke, primarily by reducing systemic inflammation, which can ...

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...

The researchers also looked at the risk of specific types of ischemic stroke: thrombotic strokes, caused by a blood clot in large arteries in the brain; cardioembolic strokes, caused by a clot ...

Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in ...

The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...

Novartis to buy Boston-based clinical-stage biopharma company, Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced tha ...

Basel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...

Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in ...